Two medical conditions have been added to the state’s list of conditions eligible for treatment with medical cannabis
Sickle cell disease and polyendocrine metabolic ovarian syndrome with chronic pain — formerly known as polycystic ovary syndrome — were added Tuesday by the Illinois Department of Public Health after review by the department’s staff and the Medical Cannabis Advisory Board the department’s director
Article continues below this ad
The medical conditions now can qualify Illinois residents for participation in the state’s Medical Cannabis Patient Program, according to the department.Cannabis can provide relief from the pain associated with the two conditions, according to the department
Under Illinois law, the department’s director reviews requests to add conditions to the list, considering available scientific analysis and medical literature in the process
“Medical cannabis can provide relief for people living with certain debilitating conditions,” Vohra said. “IDPH reviews petitions carefully using expert opinion and the most up-to-date evidence to make decisions that best serve Illinois residents. We look forward to working with our medical providers to ensure safe, appropriate access for individuals struggling with these newly approved conditions.”
Polyendocrine metabolic ovarian syndrome is characterized by hormonal fluctuations that impact metabolism, reproductive health, skin, and mental well-being
Article continues below this ad
Sickle cell disease refers to a group of inherited red blood cell disorders in which abnormal blood cells can lead to extreme pain, anemia, fatigue, swelling, infections and organ damage
Medical providers now can begin certifying patients with either condition for treatment using medical cannabis
For a full list of eligible conditions, go to dph.illinois.gov
